Evidence map›Paper›PMID 29899320›Full record

ReviewDiseases (Basel, Switzerland)2018

Pancreatic Cystic Lesions: Pathogenesis and Malignant Potential.

Antoinette J Pusateri, Somashekar G Krishna

Abstract readReview
In one paragraph

Review in Diseases (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Precision Medicine in Cytopathology.Surgical pathology clinics · 2024
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Pancreatic Cancer Surveillance: Who, When, and How.Current treatment options in gastroenterology · 2019
    Review
  11. Intra-Ampullary Papillary-Tubular Neoplasm: A Population-Based Analysis.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  12. Article
  13. Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma.Frontiers in bioengineering and biotechnology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Antoinette J PusateriDepartment of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA. Antoinette.Pusateri@osumc.edu.
Somashekar G KrishnaDivision of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA. Somashekar.Krishna@osumc.edu.ORCID 0000-0001-5748-7890

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic cancer remains one of the most lethal cancers despite extensive research. Further understanding of precursor lesions may enhance the ability to treat and prevent pancreatic cancer. Pancreatic cystic lesions (PCLs) with malignant potential include: mucinous PCLs (intraductal papillary mucinous neoplasms and mucinous cystic neoplasm), solid pseudopapillary tumors and cystic neuroendocrine tumors. This review summarizes the latest literature describing what is known about the pathogenesis and malignant potential of these PCLs, including unique epidemiological, radiological, histological, genetic and molecular characteristics.

Indexed as

cystic neuroendocrine tumorsintraductal pancreatic mucinous neoplasmmucinous cystic neoplasmmucinous lesionspancreatic cystic lesionspancreatic ductal adenocarcinomasolid pseudo-papillary tumors

Identifiers

PMID29899320
PMCPMC6023528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.